The file's text, extracted by GovTribe without its formatting.
Continuation of SF-1449, Block 3:
The following information shall be entered by the Contracting Officer at the time of contract award according to the timeframes specified in this solicitation’s Section B, Scope of Contract, Section 1.4 Contract Effective Date, Implementation Period, and Ordering Period.
Contract Award/Effective Date: ___________________
Implementation Period: __________________________
Ordering Period (Base Year): _____________________
Offerors shall not enter information into the above fields.
Continuation of SF-1449, Blocks 19 through 24:
Group 1 (line items 1, 2, 3a or 3b, 4, 5, and 6a or 6b), and Group 2 (line items 1 and 2) represent two separate requirements for purposes of FAR Clause 52.217-9, “Option to Extend the Terms of the Contract” and Clause 52.233-2 “Service of Protest”. For the purpose of determining the lowest-priced, technically acceptable offer(s) the Government will evaluate each group separately. To be considered for award for Group 1, offerors are required to submit prices for Group 1 – line items 1, 2, 3a or 3b, 4, 5, and 6a or 6b for the base and all four option years. To be considered for award for Group 2, offerors are required to submit prices for Group 2 – line item 1 and 2 for the base and all four option years. Offered prices shall not exceed two decimal places.
Award will be made in the aggregate for Group 1 (line items 1, 2, 3a or 3b, 4, 5, and 6a or 6b); and Group 2, (line items 1 and 2). The Government may award two separate contracts for Group 1 and Group 2, or one contract for both groups.
Line items 1 and 4 are unit of use. All unit-of-use packaging identified in the Schedule of Supplies (i.e., 90s) shall contain a safety-cap capable of having the outer part of the cap deshelled and/or a convertible cap to produce a non-safety cap and a bottle with a minimum required size of 120cc volume. The safety cap must not exceed the diameter of the bottle. The bottle must have a cylindrical body and minimum of 5.75” circumference. The bottle must fit a label with a dimension of 5.25” x 2”. The 0.5” additional space is required to keep the bar code exposed and/or allow for the display of the expiration date and lot number.
Note: NDC is defined as National Drug Code. ANDA is defined as Abbreviated New Drug Application
Group 1 (OGAs)
Line Item 1 - Omeprazole DR 20mg Capsules, 90 Capsules per Bottle (Unit of Use)
NDC # __________________ ANDA#______________________
| Schedule of Supplies |
| Quantity |
| Unit |
| Unit Price |
| Amount (Unit Price x Quantity) |
| Option Year One |
| 238 |
| Bottles |
| Option Year Two |
| 238 |
| Bottles |
| Option Year Three |
| 238 |
| Bottles |
| Option Year Four |
| 238 |
| Bottles |
Line Item 2 -Omeprazole DR 20mg Capsules, 100 Capsules per Bottle
NDC # __________________ ANDA#__________________
| Schedule of Supplies |
| Quantity |
| Unit |
| Unit Price |
| Amount (Unit Price x Quantity) |
| Option Year One |
| 1,633 |
| Bottles |
| Option Year Two |
| 1,633 |
| Bottles |
| Option Year Three |
| 1,633 |
| Bottles |
| Option Year Four |
| 1,633 |
| Bottles |
3a OR 3b
Line Item 3a - Omeprazole DR 20mg Capsules, 500 Capsules per Bottle
NDC # __________________ ANDA#_________________
| Schedule of Supplies |
| Quantity |
| Unit |
| Unit Price |
| Amount (Unit Price x Quantity) |
| Option Year One |
| 36,848 |
| Bottles |
| Option Year Two |
| 36,848 |
| Bottles |
| Option Year Three |
| 36,848 |
| Bottles |
| Option Year Four |
| 36,848 |
| Bottles |
OR
Line Item 3b - Omeprazole DR 20mg Capsules, 1000 Capsules per Bottle
NDC # __________________ ANDA#_________________
| Schedule of Supplies |
| Quantity |
| Unit |
| Unit Price |
| Amount (Unit Price x Quantity) |
| Option Year One |
| 18,424 |
| Bottles |
| Option Year Two |
| 18,424 |
| Bottles |
| Option Year Three |
| 18,424 |
| Bottles |
| Option Year Four |
| 18,424 |
| Bottles |
Line Item 4 - Omeprazole DR 40mg Capsules, 90 Capsules per Bottle (Unit of Use)
NDC # _______________________ ANDA#_________________
| Schedule of Supplies |
| Quantity |
| Unit |
| Unit Price |
| Amount (Unit Price x Quantity) |
| Option Year One |
| 562 |
| Bottles |
| Option Year Two |
| 562 |
| Bottles |
| Option Year Three |
| 562 |
| Bottles |
| Option Year Four |
| 562 |
| Bottles |
Line Item 5 -Omeprazole DR 40mg Capsules, 100 Capsules per Bottle
NDC # __________________
ANDA#___________________________________
| Schedule of Supplies |
| Quantity |
| Unit |
| Unit Price |
| Amount (Unit Price x Quantity) |
| Option Year One |
| 592 |
| Bottles |
| Option Year Two |
| 592 |
| Bottles |
| Option Year Three |
| 592 |
| Bottles |
| Option Year Four |
| 592 |
| Bottles |
6a OR 6b
Line Item 6a - Omeprazole DR 40mg Capsules, 500 Capsules per Bottle
NDC # __________________
ANDA#_________________
| Schedule of Supplies |
| Quantity |
| Unit |
| Unit Price |
| Amount (Unit Price x Quantity) |
| Option Year One |
| 11,728 |
| Bottles |
| Option Year Two |
| 11,728 |
| Bottles |
| Option Year Three |
| 11,728 |
| Bottles |
| Option Year Four |
| 11,728 |
| Bottles |
OR
Line Item 6b - Omeprazole DR 40mg Capsules, 1000 Capsules per Bottle
NDC # __________________
ANDA#_________________
| Schedule of Supplies |
| Quantity |
| Unit |
| Unit Price |
| Amount (Unit Price x Quantity) |
| Option Year One |
| 5,864 |
| Bottles |
| Option Year Two |
| 5,864 |
| Bottles |
| Option Year Three |
| 5,864 |
| Bottles |
| Option Year Four |
| 5,864 |
| Bottles |
Group 2 (VA)
Line Item 1 - Omeprazole DR 20mg Capsules, Bulk
NDC # __________________ ANDA#_________________
| Schedule of Supplies |
| Quantity |
| Unit |
| Unit Price |
| Amount (Unit Price x Quantity) |
| Drum or PKG Size |
| Base Year |
| 272,800,000 |
| Capsules |
| Option Year One |
| 272,800,000 |
| Capsules |
| Option Year Two |
| 272,800,000 |
| Capsules |
| Option Year Three |
| 272,800,000 |
| Capsules |
| Option Year Four |
| 272,800,000 |
| Capsules |
Line Item 2 - Omeprazole DR 40mg Capsules, Bulk
NDC # __________________ ANDA#_________________
| Schedule of Supplies |
| Quantity |
| Unit |
| Unit Price |
| Amount (Unit Price x Quantity) |
| Drum or PKG Size |
| Base Year |
| 61,000,000 |
| Capsules |
| Option Year One |
| 61,000,000 |
| Capsules |
| Option Year Two |
| 61,000,000 |
| Capsules |
| Option Year Three |
| 61,000,000 |
| Capsules |
| Option Year Four |
| 61,000,000 |
| Capsules |
** The minimum package size for Group 2 (bulk) is 1,000 tablet count. The 1,000 tablet count will be accepted for Group 2 but a larger package size such as 10,000 Tablet drums or larger are desired for the bulk (See Section 1.5 in the Scope of Contract section of this solicitation)
For each of the drug strengths listed in Group 2. For the base year only or earlier, if an offeror is not able to provide the drug in larger quantities i.e. 10,000 Tablet drums or larger, VA will accept 1,000 count bottles. When VA exercises the first option year, the successful offeror awarded the contract under this solicitation must provide in quantities of at 10,000 count drums for each of the strengths.
For the purpose of evaluating offers, $0.0314 (VA awarded repackaging fee) per bottle will be added if the bottle is under 10,000 tablet count required to meet the estimated annual requirements. For example, if 1000 count bottles were proposed for Group 2, item 2 (which has estimated annual requirements of 51,000,000 capsules), $.0314 would be multiplied by 51,000. This figure would be added to the total annual price for price evaluation purposes. The $0.0314 per bottle represents the repackaging cost to the Government during the base year of contract performance for a contract awarded under this solicitation and will be included in the calculation of the lowest total aggregate price for evaluation of award.
** The estimated annual usage cited above is the Government’s total estimated usage for the strength and bottle size/capsule count listed. There is no expressed or implied guarantee that the estimated quantities will be purchased under this contract. Actual quantities purchased may exceed or be less than those represented.
***Bulk Product (GROUP 2) must have at least 18 months of dating prior to product expiration on the date of shipment from the contract holder to the Pharmaceutical Repackager.
****Price Evaluation note:
| GROUP 1 will be evaluated based on unit prices (per bottle price) |
| GROUP 2 will be evaluated based on unit prices (per capsule price) |
+ 0.0314 if the tablet count is 1,000 as described above.